Monovisc
WHAT IS MONOVISC ?
Monovisc® is a single injection viscosupplement utilized to treat knee joint pain caused by osteoarthritis (OA). It is comprised of highly purified, partially cross-linked sodium hyaluronate (NaHA) in a phosphate buffered saline solution, and it is both biocompatible and resorbable.
With just one injection, Monovisc may provide pain relief that lasts for up to 6 months.1 It is the only non-animal sourced hyaluronic acid (HA) single-injection treatment approved for use in the United States, and it delivers the maximum dose of HA (88mg) currently available in any single injection treatment.
Unique Features of Monovisc are
Highest FDA-approved HA Available in the market.
– Data on file
What is the efficacy for Monovisc4?
Monovisc provides greater and faster pain relief that other Viscosupplement.
- Pain relief as early as 2 weeks and
- longer lasting pain relief up to 26 weeks.
Reference 4: Michael J. Daley. 2013. White paper: Clinical Efficacy and Safety of MONOVISC™: A lightly cross-linked highly concentrated hyaluronan specially formulated for single injection in osteoarthritis. AML 900-017 rev.A
MONOVISC product video